Georges CaouetteM.D.

Guillot M, Synnes A, Pronovost E, Qureshi M, Daboval T, Caouette G, Olivier F, Bartholomew J, Mohamed I, Massé E, Afifi J, Hendson L, Lemyre B, Luu TM, Strueby L, Cieslak Z, Yusuf K, Pelligra G, Ducruet T, Ndiaye ABKT, Angoa G, Sériès T, Piedboeuf B, Nuyt AM, Fraser W, Mâsse B, Lacaze-Masmonteil T, Lavoie PM, Marc I

Maternal High-Dose DHA Supplementation and Neurodevelopment at 18-22 Months of Preterm Children

Pediatrics, 150 (1), 2022.

Résumé | Liens:

Guillot M, Robitaille CA, Turner L, Pronovost E, Caouette G, Matte-Gagné C, Olivier F, Bartholomew J, Massé É, Morin A, Mohamed I, Marc I

Effects of maternal docosahexaenoic acid supplementation on brain development and neurodevelopmental outcomes of breastfed preterm neonates: protocol for a follow-up at preschool age of a randomised clinical trial (MOBYDIckPS)

BMJ Open, 12 (5), 2022.

Résumé | Liens:

Papenburg J, Defoy I, Masse E, Caouette G, Lebel MH

Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks' Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study

J Pediatric Infect Dis Soc, 10 (3), 2021.

Résumé | Liens:

Papenburg J, Saleem M, Teselink J, Li A, Caouette G, Massé É, Lanctôt KL

Cost-analysis of Withdrawing Immunoprophylaxis for Respiratory Syncytial Virus in Infants Born at 33-35 Weeks Gestational Age in Quebec: A Multicenter Retrospective Study

Pediatr Infect Dis J, 39 (8), 2020.

Résumé | Liens:

Marc I, Piedboeuf B, Lacaze-Masmonteil T, Fraser W, Masse B, Mohamed I, Qureshi M, Afifi J, Lemyre B, Caouette G, Bartholomew J, Nuyt AM, Julien P, Synnes A, Lucas M, Perreault T, Strueby L, Cieslak Z, Yusuf K, Pelligra G, Masse E, Larsen B, de Cabo C, Ruth C, Khurshid F, Lavoie PM

Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial

JAMA, 324 (2), 2020.

Résumé | Liens:

Olivier F, Nadeau S, Bélanger S, Julien AS, Massé E, Ali N, Caouette G, Piedboeuf B

Efficacy of minimally invasive surfactant therapy in moderate and late preterm infants: A multicentre randomized control trial

Paediatr Child Health, 22 (3), 2017.

Résumé | Liens:

Olivier F, Nadeau S, Caouette G, Piedboeuf B

Association between Apnea of Prematurity and Respiratory Distress Syndrome in Late Preterm Infants: An Observational Study

Front Pediatr, 4 , 2016.

Résumé | Liens:

Papenburg J, Hamelin ME, Ouhoummane N, Carbonneau J, Ouakki M, Raymond F, Robitaille L, Corbeil J, Caouette G, Frenette L, De Serres G, Boivin G

Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children

J Infect Dis, 206 (2), 2012.

Résumé | Liens:

Paes B, Mitchell I, Li A, Lanctot KL,

A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)

Eur J Clin Microbiol Infect Dis, 31 (10), 2012.

Résumé | Liens:

Boivin G, Caouette G, Frenette L, Carbonneau J, Ouakki M, De Serres G

Human respiratory syncytial virus and other viral infections in infants receiving palivizumab

J Clin Virol, 42 (1), 2008.

Résumé | Liens: